AstraZeneca reported $6.17B in Cash and Equivalent for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cash And Equivalent Change
Alcon AG ALC:SW USD 980M 197M
Amgen AMGN:US USD 9.3B 197M
Artemis Alpha ATS:LN GBP 2.39M 4.76M
AstraZeneca AZN:LN USD 6.17B 1.71B
AstraZeneca AZN:SS USD 6.17B 1.71B
Astrazeneca AZN:US USD 6.17B 1.71B
Bayer BAYN:GR EUR 5.17B 810M
Biogen BIIB:US USD 3.42B 256.3M
Bristol Myers Squibb BMY:US USD 9.12B 1.39B
Fresenius FRE:GR EUR 2.75B 621M
Genmab GEN:DC DKK 9.89B 484M
Gilead Sciences GILD:US USD 7.63B 2.93B
GlaxoSmithKline GSK:LN GBP 3.72B 117M
Hikma Pharmaceutical HIK:LN USD 270M 247M
Lonza Group LONN:SW CHF 1.34B 187M
Merck MRK:GR EUR 1.85B 250M
Novartis NOVN:VX USD 7.52B 1.21B
Orion ORNBV:FH EUR 332.6M 34.5M
Recordati REC:IM EUR 346.61M 27.15M
Regeneron Pharmaceuticals REGN:US USD 14.33B 10.84B
Roche Holding ROG:VX 4.99B 676M